Explore life science & biotech companies in Oxford, home to one of the world's leading biotechnology and life science clusters.
Global viral vector CDMO for cell and gene therapy
Oxford Biomedica (OXB) is a global contract development and manufacturing organisation specialising in viral vectors for cell and gene therapy. The company provides lentiviral, adeno-associated virus (AAV), and adenoviral vector development and manufacturing services from early-stage process development through to…
Benchtop super-resolution microscopes for single-molecule biological imaging
Oxford Nanoimaging (ONI) is an Oxford-based manufacturer of compact super-resolution fluorescence microscopes and consumable application kits for life science research. Its instruments enable researchers to visualise individual proteins, DNA, RNA, viruses, and nanoparticles at 20 nanometre resolution without…
Genomic diagnostics products for cytogenetics, oncology and rare disease
Oxford Gene Technology is a genomic diagnostics company developing and manufacturing hybridisation-based reagents and assays for clinical and research laboratories. Its product portfolio spans FISH probes, chromosomal microarrays and next-generation sequencing panels, enabling detection of chromosomal abnormalities…
One-step encapsulation drug delivery platform for advanced therapeutics
PNAS Therapeutics is a UK-based drug delivery company developing a one-step encapsulation platform designed to simplify complex pharmaceutical manufacturing processes. The platform enhances local delivery through improved bioavailability and targeting, is compatible with multiple active pharmaceutical ingredients, and…
Transformative medicines for cystic fibrosis and serious genetic diseases
Vertex Pharmaceuticals is a global biopharmaceutical company with its European R&D headquarters at Milton Park, Oxfordshire, and its international commercial headquarters in London. The Oxford site conducts full-spectrum drug discovery encompassing human genetics, structural biology, and medicinal chemistry, and has…
Target discovery platform and antibody-based therapies for oncology
Oxford BioTherapeutics is an Oxford-based clinical-stage oncology company discovering and developing first-in-class antibody-based cancer therapies. Its proprietary platform identifies novel membrane protein targets directly from patient tumour samples, enabling the development of ADCs, immuno-oncology antibodies,…
Life science and deeptech innovation hub in Oxford's Headington
Wood Centre for Innovation is a purpose-built science park providing R&D laboratory space, offices and co-working facilities for early-stage life science and deeptech companies. Operated by the charity The Oxford Trust, it forms part of Oxford's Headington Science Cluster, close to the University of Oxford's Old Road…
Multi-disciplinary science and innovation campus with a major life sciences cluster
Harwell Science and Innovation Campus is a 700-acre science and technology campus in Oxfordshire, founded in 1946 and home to over 200 organisations. Managed by a joint venture of the Science and Technology Facilities Council, UK Atomic Energy Authority, and Brookfield, the campus hosts three thematic clusters in…
Real-world mental health and dementia data platform for drug development
Akrivia Health is a software company providing a real-world data and AI platform for neuroscience research and drug development. Its dataset of de-identified electronic health records from 6.3 million patients across 20 NHS Trusts covers mental health and dementia conditions, enriched through proprietary natural…
Infectious disease antigens and antibodies for diagnostics and research
The Native Antigen Company is a manufacturer of native and recombinant antigens, antibodies, and immunoassays for viral and bacterial infectious disease targets. Products are supplied to IVD manufacturers, pharmaceutical companies, and academic institutions for use in immunoassay development, serology, vaccine…
Global crop protection, seed and digital agriculture solutions provider
Corteva Agriscience UK is the British operating subsidiary of Corteva, Inc., a global agriculture company formed from the DuPont Pioneer, Dow AgroSciences and DuPont Crop Protection businesses. The company supplies Pioneer and Brevant seed varieties, crop protection products including herbicides, insecticides and…
Programmable cell-killing particle platform for targeted therapeutic delivery
Granza Bio is a biotechnology company developing a cell-targeted delivery platform based on supramolecular attack particles, naturally occurring structures used by cytotoxic T cells and natural killer cells to deliver lethal payloads with precision. The company is engineering programmable versions of these particles,…
Precision medicines targeting protein isoforms for neuromuscular disease
ISOgenix is a biotechnology company developing precision medicines that target disease-relevant protein isoforms for neuromuscular and neurological conditions. The company's approach focuses on identifying and modulating specific isoforms produced through alternative gene splicing and epigenetic regulation, aiming to…
Chemical reagents and contract manufacturing for pharma and diagnostics supply chains
Biosynth Limited is the UK manufacturing and research entity of Biosynth, a global life sciences reagents and contract development and manufacturing organisation. Its Compton, Berkshire site specialises in complex chemical synthesis including carbohydrates, nucleosides, and enzyme substrates, supplying critical raw…
Peptide discovery platform targeting cell-surface therapeutic targets
Orbit Discovery is a drug discovery company providing peptide lead identification services using a proprietary bead-based peptide display engine combined with microfluidic functional screening. The platform screens libraries of over one billion natural and non-natural peptides against challenging cell-surface targets,…
Engineered T cell receptor therapies for solid tumour cancers
Adaptimmune is a clinical-stage biopharmaceutical company developing engineered T cell receptor therapies targeting solid tumours. The company's T-cell platform engineers T cell receptors with enhanced affinity for cancer-associated antigens, enabling immune recognition of tumour cells that evade conventional…
Viral vector platform for solid tumour immunotherapy
Akamis Bio is a clinical-stage oncology company developing oncolytic adenoviral therapeutics for solid tumours. Its platform delivers immunotherapeutic payloads directly to tumour sites following intravenous dosing, enabling tumour-localised expression of proteins including CD40 agonist antibodies and cytokines. Lead…
Microbial biosynthetic pathways for novel biocatalysts and chemicals
ErebaGen is an industrial biotechnology company using engineered microorganisms to discover enzymes and chemistry from specialised microbial metabolism. Its platform activates normally silent biosynthetic gene clusters, combining computational pathway prediction, genetic engineering and high-throughput…
Mitochondrial sulfide-donor therapeutics for obesity and myopathies
MitoRx Therapeutics is a company developing first-in-class small molecule therapeutics that target mitochondrial sulfide signalling, a mechanism implicated in metabolic dysfunction and muscle disease. Its lead programme is an injectable mitochondria-targeted sulfide donor designed to achieve fat loss without lean mass…
National facility for mouse genetics and preclinical disease modelling
The Mary Lyon Centre at MRC Harwell is the UK's national centre for mouse genetics, providing mouse model generation, phenotyping, cryopreservation, and archiving services to academic and industry researchers worldwide. The Centre offers genome engineering using CRISPR and other techniques to create genetically…